Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
Marine Gilabert, Jean‐Luc Raoul
Journal of Hepatocellular Carcinoma (2018) Vol. Volume 5, pp. 91-98
Open Access | Times Cited: 11

Showing 11 citing articles:

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
Clifford Akateh, Sylvester M. Black, Lanla Conteh, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 28, pp. 3704-3721
Open Access | Times Cited: 132
Review article: new therapeutic interventions for advanced hepatocellular carcinoma
Saroja Bangaru, Jorge A. Marrero, Amit G. Singal
Alimentary Pharmacology & Therapeutics (2019) Vol. 51, Iss. 1, pp. 78-89
Closed Access | Times Cited: 94
Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook
Yinjie Fan, Hang Xue, Hua‐chuan Zheng
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 233-263
Open Access | Times Cited: 46
Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
Hang Sun, Huayu Yang, Yilei Mao
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis
Haiyi Long, Tongyi Huang, Xiaoyan Xie, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 21, pp. 5754-5768
Open Access | Times Cited: 17
ER stress signaling at the interphase between MASH and HCC
Younis Hazari, Éric Chevet, Béatrice Bailly-Maître, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
New Therapeutic Options for Advanced Hepatocellular Carcinoma
Yu‐Shui Ma, Ji‐Bin Liu, Ting‐Miao Wu, et al.
Cancer Control (2020) Vol. 27, Iss. 3
Open Access | Times Cited: 18
Therapy in Advanced Hepatocellular Carcinoma
Hanna Javan, Farshid Dayyani, Nadine Abi‐Jaoudeh
Seminars in Interventional Radiology (2020) Vol. 37, Iss. 05, pp. 466-474
Open Access | Times Cited: 15
Circumsporozoite Protein of Plasmodium berghei- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-b-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma Cells
Elise Vène, Kathleen Jarnouen, Catherine Ribault, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 804-804
Open Access | Times Cited: 5
Indonesian consensus on systemic therapies for hepatocellular carcinoma
Irsan Hasan, Imelda Maria Loho, Poernomo Boedi Setiawan, et al.
Asia-Pacific Journal of Clinical Oncology (2022) Vol. 19, Iss. 1, pp. 263-274
Closed Access | Times Cited: 2
Ramucirumab-Induced Hepatocellular Carcinoma Rupture and Gastrointestinal Perforation
Asim Haider, Ayesha Siddiqa, Maham Mehmood, et al.
American Journal of Case Reports (2021) Vol. 22
Open Access | Times Cited: 1
Page 1

Scroll to top